These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 1578346

  • 1. [Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery].
    Arima H, Kondo T, Irie T, Hirayama F, Uekama K, Miyaji T, Inoue Y.
    Yakugaku Zasshi; 1992 Jan; 112(1):65-72. PubMed ID: 1578346
    [Abstract] [Full Text] [Related]

  • 2. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
    Arima H, Kondo T, Irie T, Uekama K.
    J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
    [Abstract] [Full Text] [Related]

  • 3. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
    Arima H, Miyaji T, Irie T, Hirayama F, Uekama K.
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration.
    Puglisi G, Ventura CA, Spadaro A, Campana G, Spampinato S.
    J Pharm Pharmacol; 1995 Feb; 47(2):120-3. PubMed ID: 7602465
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H, Yunomae K, Miyake K, Irie T, Hirayama F, Uekama K.
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [Abstract] [Full Text] [Related]

  • 14. Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats.
    Nagarsenker MS, Meshram RN, Ramprakash G.
    J Pharm Pharmacol; 2000 Aug; 52(8):949-56. PubMed ID: 11007065
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ibuprofen-in-cyclodextrin-in-W/O/W emulsion - Improving the initial and long-term encapsulation efficiency of a model active ingredient.
    Hattrem MN, Kristiansen KA, Aachmann FL, Dille MJ, Draget KI.
    Int J Pharm; 2015 Jun 20; 487(1-2):1-7. PubMed ID: 25839416
    [Abstract] [Full Text] [Related]

  • 19. Encapsulation and Stabilization of α-Lipoic Acid in Cyclodextrin Inclusion Complex Electrospun Nanofibers: Antioxidant and Fast-Dissolving α-Lipoic Acid/Cyclodextrin Nanofibrous Webs.
    Celebioglu A, Uyar T.
    J Agric Food Chem; 2019 Nov 27; 67(47):13093-13107. PubMed ID: 31693349
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.